Statins are the most widely prescribed, cholesterol-lowering drugs in the world. The number of events prevented will continue to grow past five years since statin therapy further reduces ASCVD risk during each year it continues to be taken. In general, statins … Statins clearly help to lower the risk for future ASCVD events in patients at risk. So, statins likely … The first is that medical personnel should aggressively use statins … As far as whether you should use statins, Basu said it's important to have that conversation with your doctor. People over 40 who have at least a 7.5% risk of stroke or heart disease … The one trial that did, STOMP, found statins did not decrease muscle strength or exercise performance but there were more complaints of muscle pain compared to placebo (9.3 vs. 4.6%). Despite the expiration of their patents, revenue for statins is expected to rise, with total sales on track to reach an estimated US$1 trillion by 2020. 2018 American Heart Association Scientific Session Guidelines. A bitter dispute has erupted among doctors over suggestions that statins … 3. Johns Hopkins Medicine announced that the 2018 American Heart Association Scientific Session calls for two changes in the prevention of atherosclerosis and heart disease.